University Texas Researchers Found Reasons For Blood Clotting Disorder

Researchers find the reason for blood clotting disorder

11:31 AM, 28th August 2013
University of Texas Research News
Dianna Milewicz, Professor, University of Texas.

HOUSTON, US: Research team at The University of Texas has found the variation that was causing the clotting problem in the case it wasn’t hemophilia. Dianna Milewicz, Professor, University of Texas collaborated with Bjorn Dahlback, MD, PhD, from Lund University, Malmo, Sweden, to pinpoint exactly how the variation was causing the clotting problem.

“No surgeon would do elective surgery because they bled too much after surgery. So we collected DNA and plasma from the family and were able to determine that a genetic variant in the Factor V gene was causing production of an abnormal form of the Factor V protein, which we called FV-Short. Factor V is a protein known to be important for the blood to clot. Dr Dahlback is a world expert on Factor V and he was very excited about the research,” said Milewicz.

“I was indeed very excited when hearing about the puzzling results because the knowledge at the time on the role of FV in coagulation could not explain the bleeding disorder. It has been a great privilege to work with Dr Milewicz and her colleagues to decode the unexpected and intriguing mechanisms on how FV-Short caused the bleeding disorder,” said Dahlback.

Genes make proteins that do everything from giving cells shape and structure to helping carry out biological processes. To make the proteins, genes go through a process called alternative splicing that creates coded portions, called exons. The researchers discovered that a mutation in exon 13 of the coagulation FV gene caused a short form of the protein due to changes in the splicing of the exons. That FV-Short protein was unexpectedly found to form a complex in blood with tissue factor pathway inhibitor (TFPI), a protein that inhibits coagulation of the blood. An overabundance of the combined FV-Short/TFPI in the bloodstream keeps the blood from clotting in the affected family members. Other researchers have been looking at ways to inhibit TFPI, which could lead to a treatment for this family’s clotting disorder.

What Milewicz called traditional genetics and “old-fashioned biochemistry” by lead co-author Lisa Vincent, PhD, led to the discovery of the FV-short protein in the blood of affected family members. Dahlback’s work determined how the FV-Short was causing the problems with clotting the blood. Milewicz said studying this family with a rare blood disorder has provided further insight into how the blood clots.

“We knew there was something wrong with these patients’ FV, but proving it required discovering unique properties of FV in coagulation. After many trials and tribulations, our true success is finally being able to provide an answer to the family about their medical issues,” said Vincent.

 

© The University of Texas News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Enthusiastic students attend Edinburgh International Science Festival 2013

BANGALORE, INDIA: The 26th Edinburgh International Science Festival (EISF) was held in Bangalore, India for 10 days from August 30 to 8 September 2013 ...

Read more
Technip, HQC form JV in Italy, China

PARIS, FRANCE: Technip’s operating centre in Rome, Italy, has signed an agreement with China Huanqiu Contracting & Engineering Corporation ( ...

Read more
More than 3000 chemicals in human urine reveals new study

EDMONTON, CANADA: Researchers at the University of Alberta have determined the chemical composition of human urine - and the results reveal a remarkab ...

Read more
KBR bags DuPont’s contract in US gulf coast

HOUSTON, US: KBR, a global engineering, construction and services company, has secured a five year extension to provide contracted construction and ma ...

Read more
Eastman changes board members

KINGSPORT, US: Eastman Chemical Company announced changes in its executive management. Ronald C Lindsay has been appointed Chief Operating Officer, Br ...

Read more
Cabot, Risun complete construction of carbon black facility in China

XINGTAI, CHINA/BOSTON, US: Cabot Corporation and joint venture partner Risun Group have completed and commissioned their new carbon black manufacturin ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X